Show
Sort by
-
Exploiting the synergistic effect of PARP inhibition with cisplatin and hyperthermia during interval cytoreductive surgery and HIPEC in ovarian cancer : the PROOV study : a phase I/II clinical trial
(2026) INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. In International Journal of Gynecological Cancer 36(2, Supplement 1). -
- Journal Article
- A1
- open access
Improving pre-operative binary grading : relevance of p53 and PR expression in grade 2 endometrioid endometrial carcinoma
-
Outcomes of patients with early stage mucinous ovarian carcinoma : a Dutch population-based cohort study comparing expansile and infiltrative subtypes
-
- Journal Article
- A1
- open access
A phase II, multicenter, open-label study of abemaciclib and letrozole in patients with estrogen receptor-positive rare ovarian cancer : ALEPRO trial
-
- Journal Article
- A1
- open access
Quality assurance in human papillomavirus testing for primary cervical screening
-
Endometrial carcinosarcoma
-
2022-RA-638-ESGO Pembrolizumab with multimodal immunomodulation in chemotherapy-pretreated cervical, endometrial, and uterine cancer : the PRIMMO phase II trial
(2022) INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. In International Journal of Gynecological Cancer 32(Supplement 2). p.A187-A188 -
Prospective non-interventional BELOVA/BGOG-ov16 study on safety of frontline bevacizumab in elderly patients with FIGO stage IV ovarian cancer : a study of the Belgian and Luxembourg Gynaecological Oncology Group
-
- Journal Article
- A1
- open access
Myths and fake messages about human papillomavirus (HPV) vaccination : answers from the ESGO Prevention Committee
-
The IJGC editorial fellowship